Page 27 - உலகளாவிய ஆரோக்கியம் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data: Duke Global Health Innovation Center; Chart: Michelle McGhee/AxiosThe Biden administration’s purchase of 200 million additional Pfizer and Modern doses means the U.S. could fully vaccinate 300 million people with just those two vaccines — and 355 million more people if four additional vaccines gain FDA approval.Why it matters: The U.S. is home to 250 million adults, many of whom won’t elect to be vaccinated. It's also now in control of a big chunk of the global vaccine supply. The White House says the U.S. will eventually donate excess doses to other countries, but it hasn’t released a plan to do so. Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeThe state of play: The administration has been focused almost entirely on ensuring that every American who wants a vaccine will be able to get one by this summer. With the additional Pfizer and Moderna doses — and up to 40 million Johnson &

United statesWhite houseDistrict of columbiaZeke emanuelMichelle mcghee axiosDonald trumpKrishna udayakumarAnthony fauciJen psakiDuke global health innovation centerDuke university global health innovation centerUniversity of pennsylvaniaState departmentHouse press secretary jen psakiDuke universityGlobal health innovation